Stay updated on Nivolumab vs Temozolomide in GBM Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.

Latest updates to the Nivolumab vs Temozolomide in GBM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.5.4 has been added and the previous Revision: v3.5.3 has been removed on the page. This reflects an internal update to the page’s versioning label rather than a change to user-facing content or functionality.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page’s site footer version has been updated from **v3.5.2** to **v3.5.3**, indicating a minor platform/content delivery revision rather than any change to the study record.SummaryDifference0.0%

- Check37 days agoChange DetectedThe collaborator entry was updated to Ono Pharmaceutical Co., Ltd. (replacing Ono Pharmaceutical Co. Ltd). The document revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded Padova, Italy, 35128 and removed Padua, Italy, 35128 from the locations list.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Temozolomide in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.